Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $80.54 USD
Change Today +4.46 / 5.86%
Volume 677.7K
CLVS On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Patrick J. Mahaffy MA

Co-Founder, Chief Executive Officer, President and Director,Clovis Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 24 board members in 3 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Patrick J. Mahaffy, M.A, co-founded Clovis Oncology, Inc. on April 20, 2009 and has been its Chief Executive Officer and President since April 20, 2009. Mr. Mahaffy serves as the Chief Executive Officer of Pharmion GmbH. He founded Pharmion LLC in August 1999 and served as its Chief Executive Officer and President since August 1999. He has significant biotechnology and pharmaceutical executive management experience. From June 1992 to 1998, he served as the Chief ...

Read Full Background

Corporate Headquarters*

2525 28th Street
Boulder, Colorado 80301

United States

Phone: 303-625-5000
Fax: 303-245-0360

Board Members Memberships*

Director, Chairman of Nominating/Corporate Governance Committee and Member of Compensation Committee
Co-Founder, Chief Executive Officer, President and Director
Chairman, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee


Columbia University
Lewis & Clark College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$901,667

Stock Options*

All Other Compensation$15,146
Exercisable Options190,625
Exercisable Options Value$6,215,313
Unexercisable Options359,375
Unexercisable Options Value$5,311,688
Total Value of Options$11,527,000
Total Number of Options550,000

Total Compensation*

Total Annual Cash Compensation$916,813
Total Short Term Compensation$901,667
Other Long Term Compensation$15,146
Total Calculated Compensation$10,123,033
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLVS:US $80.54 USD +4.46


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CLOVIS ONCOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at